In clear cell renal cell carcinoma (ccRCC) (Fig. 5), the expression of FTO was found to be elevated, while m6A modification levels were reduced compared to neighboring noncancerous tissues. The gene discussed is FTO; the disease is nonpapillary renal cell carcinoma.